Lisinopril Cost in Kansas (2026): Cash Prices, Insurance, Medicaid & Savings

What Generic Lisinopril Actually Costs at Kansas Pharmacies

A 30-day supply of generic lisinopril averages $8 at retail pharmacies across Kansas in 2026. That figure covers the most commonly prescribed strengths (10 mg, 20 mg, and 40 mg tablets) and reflects cash-pay pricing without insurance or discount cards applied.

The manufacturer list price for various generic versions sits around $50 per month, but almost nobody pays that. Kansas has a competitive generic dispensing market, and large chain pharmacies (CVS, Walgreens, Walmart, Hy-Vee) routinely price lisinopril on their $4-per-month generic lists. Independent pharmacies in rural Kansas counties may charge slightly more, typically $6 to $12, depending on their wholesaler agreements.

Prices can also shift by dosage. The 2.5 mg and 5 mg strengths sometimes cost marginally more per tablet because they move in lower volume. The 10 mg and 20 mg tablets, prescribed most often, tend to sit at the floor price. A 2023 analysis of ACE inhibitor prescribing patterns published in the Journal of the American Heart Association found that lisinopril accounted for 46% of all ACE inhibitor prescriptions in the United States, a dominance that drives generic competition and keeps per-unit costs low.

For patients filling 90-day supplies through mail-order pharmacies, the per-month cost drops further. Several Kansas-based mail-order options charge $9 to $12 for a full 90-day supply, effectively bringing the monthly cost below $4. Walmart's $10-for-90-days program remains available at Kansas locations as of early 2026.

Kansas Medicaid Coverage for Lisinopril

Kansas Medicaid (KanCare) covers lisinopril, but with a specific restriction: coverage applies to patients with a type 2 diabetes diagnosis, not to hypertension alone. This is an important distinction that catches many patients off guard.

The restriction reflects Kansas's preferred drug list (PDL) structure, where ACE inhibitors carry indication-based coverage tiers. Patients with a documented T2D diagnosis who also have hypertension or chronic kidney disease will find lisinopril covered under KanCare without prior authorization, consistent with the ADA Standards of Care recommendation that ACE inhibitors serve as first-line agents for diabetic nephropathy prevention.

For Medicaid beneficiaries whose only diagnosis is hypertension, the options are different. Kansas KanCare managed care organizations (MCOs) may cover alternative ACE inhibitors or ARBs on their preferred lists. Amlodipine, a calcium channel blocker, is covered without restriction and may be substituted. Providers can also submit a prior authorization request citing clinical necessity.

"ACE inhibitors remain a cornerstone of cardiovascular and renal protection in patients with diabetes," states the 2024 AHA/ACC Clinical Practice Guideline for Chronic Kidney Disease. For Kansas Medicaid patients with both hypertension and diabetes, this guideline support makes prior authorization approvals relatively straightforward when documentation is submitted.

The cash price of $8 per month means that even Medicaid-ineligible patients in Kansas face minimal financial barriers. Several community health centers across Kansas, including those in Wichita, Topeka, and Kansas City (KS), offer 340B Drug Pricing Program access that can reduce costs below $3 per month for qualifying uninsured patients.

Insurance Coverage Across Kansas Plans

Most commercial insurance plans in Kansas place lisinopril on Tier 1 (preferred generic), resulting in copays between $0 and $10 for a 30-day supply. This applies to plans offered by Blue Cross Blue Shield of Kansas, Aetna, UnitedHealthcare, and Ambetter, which together cover the majority of the commercially insured Kansas population.

High-deductible health plans (HDHPs) require patients to pay the full negotiated rate until their deductible is met. Even in this scenario, the negotiated rate for lisinopril through most Kansas PBMs (pharmacy benefit managers) falls between $3 and $8, rarely exceeding the cash-pay price. Patients on HDHPs should compare their plan's negotiated rate against discount card pricing, because the discount card price is sometimes lower.

Medicare Part D plans in Kansas universally cover lisinopril. Under the Inflation Reduction Act provisions that took full effect in 2025, Medicare beneficiaries pay no more than $35 per month for covered generics in the catastrophic phase, though lisinopril's base cost is so low that this cap rarely becomes relevant. Most Part D plans charge $0 to $3 for a 30-day lisinopril supply.

Employer-sponsored plans through major Kansas employers (Spirit AeroSystems, Garmin, Cerner/Oracle Health) typically include lisinopril at $0 copay as part of preventive medication programs. The USPSTF A-grade recommendation for hypertension screening and treatment means that many plans waive cost-sharing for first-line antihypertensives entirely under ACA preventive care mandates.

Compounded Lisinopril in Kansas: Legality and Access

Compounded lisinopril is legal in Kansas through licensed 503A compounding pharmacies. These pharmacies operate under individual patient prescriptions and are regulated by the Kansas State Board of Pharmacy.

Why would anyone compound a drug that already costs $8? Compounding serves patients who need non-standard formulations. Lisinopril is commercially available only as oral tablets (2.5 mg through 40 mg) and a manufactured oral solution (Qbrelis, 1 mg/mL). Patients who cannot swallow tablets and find Qbrelis unavailable or too expensive (Qbrelis can cost $200+ per month without insurance) may benefit from a compounded suspension.

Kansas 503A pharmacies can prepare lisinopril oral suspensions, flavored liquids for pediatric patients, or capsules in non-standard doses. The FDA guidance on 503A compounding requires that these preparations be made from bulk drug substance or commercially available dosage forms, with appropriate beyond-use dating.

Compounded preparations typically cost between $15 and $45 per month in Kansas, depending on the formulation complexity. For patients who need standard tablets, compounding offers no cost advantage. For those who need liquid formulations, compounding can save $150+ per month compared to the branded Qbrelis product.

Kansas does not permit 503B outsourcing facilities to distribute compounded lisinopril without individual prescriptions. All compounded lisinopril in Kansas must flow through a patient-specific 503A prescription.

Discount Programs and Savings Cards Available in Kansas

Multiple discount pathways exist for Kansas residents filling lisinopril prescriptions, and stacking the right approach against insurance can yield meaningful savings even on an already inexpensive drug.

GoodRx, RxSaver, and SingleCare all show Kansas lisinopril prices between $3 and $7 for 30 tablets at major chain pharmacies. These prices are available without insurance and can be used by anyone, including those with coverage who find their copay exceeds the discount price. Walmart and Costco (Costco pharmacy access does not require membership) consistently post the lowest discount-card prices in the Kansas market.

The Mark Cuban Cost Plus Drugs company (costplusdrugs.com) sells lisinopril at $3.60 for a 90-day supply of 10 mg tablets, shipped to Kansas addresses. This mail-order option requires a valid prescription but no insurance. Their pricing model adds a flat 15% margin plus a $5 pharmacy fee to the manufacturer cost, resulting in prices that undercut most retail options.

Kansas-specific programs also exist. The KanCare pharmacy assistance line (1-800-792-4884) can help Medicaid-eligible patients manage formulary restrictions. Community health centers operating under HRSA Section 330 grants offer 340B pricing, which brings lisinopril costs to $1 to $3 per fill for eligible patients. There are over 40 HRSA-funded health centers operating across Kansas, with concentrations in Sedgwick County, Shawnee County, and Wyandotte County.

For patients taking lisinopril alongside other cardiovascular medications, combination discount strategies matter. A patient on lisinopril, atorvastatin, and amlodipine can fill all three generics for under $12 per month at Walmart in Kansas using their $4-per-generic program.

Telehealth Prescribing of Lisinopril in Kansas

Kansas permits telehealth prescribing of lisinopril statewide. The state's telemedicine act, updated through the Kansas Telemedicine Act (K.S.A. 40-2,215), allows licensed physicians, nurse practitioners, and physician assistants to prescribe non-controlled substances via audio-video consultation.

Lisinopril is not a controlled substance, so it faces no DEA scheduling restrictions on telehealth prescribing. A clinician licensed in Kansas (or holding a Kansas telemedicine license) can evaluate a patient remotely, review blood pressure readings and lab work, and prescribe lisinopril electronically to any Kansas pharmacy.

Several telehealth platforms serve Kansas patients for hypertension management. HealthRX offers clinician-supervised telehealth consultations that can include lisinopril prescriptions when clinically appropriate. Patients typically need recent blood pressure readings (home monitoring is acceptable) and a basic metabolic panel within the past 12 months to initiate ACE inhibitor therapy.

The telehealth pathway is particularly valuable for rural Kansas counties. Of Kansas's 105 counties, over 80 are designated as Health Professional Shortage Areas by HRSA. In these areas, a telehealth visit eliminates the need to drive 30 to 60+ miles for a prescription renewal. Combined with mail-order pharmacy fulfillment, a Kansas patient can manage stable hypertension entirely remotely.

One limitation: Kansas telemedicine law requires an initial audio-video visit. Audio-only phone consultations cannot be used for initial prescribing, though they may be used for follow-up refill visits after the provider-patient relationship is established.

How Lisinopril Compares to Other Kansas-Available ACE Inhibitors on Cost

Lisinopril is not the only ACE inhibitor available in Kansas, but it is the cheapest and most widely stocked. A cost comparison across common ACE inhibitors at Kansas retail pharmacies in 2026 shows why lisinopril dominates prescribing.

Enalapril, the second most commonly prescribed ACE inhibitor, averages $10 to $15 per month in Kansas. It requires twice-daily dosing, which also creates adherence challenges. The ALLHAT trial (N=33,357), the largest antihypertensive comparison trial ever conducted, used lisinopril as its ACE inhibitor arm and demonstrated equivalent cardiovascular mortality outcomes compared to amlodipine and chlorthalidone. ALLHAT's use of lisinopril specifically (rather than enalapril or other ACE inhibitors) reinforced its position as the default choice.

Benazepril averages $12 to $18 per month. Ramipril, which carries a specific post-MI indication from the HOPE trial (N=9,297), costs $15 to $25 per month in Kansas. Quinapril and fosinopril, used less frequently, range from $20 to $40 per month.

"Lisinopril and enalapril are considered interchangeable for most hypertension indications," notes the JNC 8 guideline panel report. "Selection among ACE inhibitors is typically driven by cost, dosing convenience, and formulary status." In Kansas, all three factors favor lisinopril.

The only scenario where a different ACE inhibitor might be preferred on clinical grounds is post-myocardial infarction management, where ramipril carries Level A evidence from the HOPE trial. Even then, Kansas cardiologists frequently use lisinopril based on the GISSI-3 trial data (N=19,394) showing post-MI mortality benefit with lisinopril specifically.

Side Effects That May Drive Costs Up

The most common reason lisinopril creates indirect costs is the ACE inhibitor cough. This dry, persistent cough affects approximately 5% to 35% of patients depending on the population studied, with higher rates in women and patients of East Asian descent.

When the cough occurs, patients often visit their physician for evaluation (office visit copay: $20 to $50 in Kansas) before attributing it to lisinopril. Some undergo chest X-rays or pulmonary function testing first. The solution is typically switching to an ARB (angiotensin receptor blocker) such as losartan, which costs $8 to $12 per month in Kansas and does not cause cough.

Angioedema is a rare but serious side effect, occurring in roughly 0.1% to 0.7% of patients. An angioedema episode can generate emergency department costs of $1,500 to $5,000 or more. Black patients face 2 to 4 times higher angioedema risk with ACE inhibitors, per data from ALLHAT and other trials. Kansas prescribers should discuss this differential risk during initial counseling.

Hyperkalemia (elevated potassium) requires periodic lab monitoring, typically a basic metabolic panel every 6 to 12 months once stable dosing is achieved. At Kansas lab facilities, a BMP costs $15 to $50 without insurance or is included in routine preventive lab draws under most plans. The FDA-approved prescribing information for lisinopril recommends checking serum potassium and creatinine within 2 to 4 weeks of initiation and after dose changes.

How to Get the Lowest Possible Price in Kansas

The optimal strategy depends on insurance status. For uninsured patients, the Cost Plus Drugs mail-order price of $3.60 for 90 days is difficult to beat. For insured patients with a $0 generic copay, using insurance is straightforward. The gap population, those with insurance but a copay exceeding $4, should compare their copay against discount card pricing at the point of sale.

Kansas pharmacists are permitted to inform patients when a discount card price is lower than their insurance copay. This was not always the case. Gag clause legislation at both the federal and Kansas state level now prohibits PBMs from restricting pharmacist communication about lower-cost alternatives.

For patients on Kansas Medicaid without a T2D diagnosis, the fastest path to covered lisinopril is asking the prescriber to submit a prior authorization with documentation of clinical necessity. Approval rates for ACE inhibitors in hypertension are high when the request cites guideline-concordant prescribing and prior trial of a preferred formulary agent.

Patients filling at a 340B-eligible community health center in Kansas pay the lowest prices of all, often $1 to $3 per 30-day supply, regardless of insurance status. Call the health center pharmacy directly to confirm 340B eligibility before your first fill.